ALB and acute kidney injury: Treatment guidelines on HRS-AKI in the United States recommend the use of albumin plus a vasoconstrictor for up to 14 days until serum creatinine (SCr) levels decrease to ≤1.5 mg/dL or within 0.3 mg/dL of baseline (2).